SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Clorox Co./DE – ‘10-K’ for 6/30/22 – ‘EX-99.2’

On:  Wednesday, 8/10/22, at 4:15pm ET   ·   For:  6/30/22   ·   Accession #:  21076-22-26   ·   File #:  1-07151

Previous ‘10-K’:  ‘10-K’ on 8/10/21 for 6/30/21   ·   Next & Latest:  ‘10-K’ on 8/10/23 for 6/30/23   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/10/22  Clorox Co./DE                     10-K        6/30/22  129:15M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    752K 
 2: EX-21       Subsidiaries List                                   HTML     59K 
 3: EX-23       Consent of Expert or Counsel                        HTML     34K 
 7: EX-99.1     Miscellaneous Exhibit                               HTML   2.36M 
 8: EX-99.2     Miscellaneous Exhibit                               HTML     67K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     35K 
14: R1          Cover Page                                          HTML     98K 
15: R2          Audit Information                                   HTML     39K 
16: R3          Consolidated Statement of Earnings                  HTML    122K 
17: R4          Consolidated Statements of Comprehensive Income     HTML     72K 
18: R5          Consolidated Balance Sheets                         HTML    158K 
19: R6          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
20: R7          Consolidated Statements of Stockholders' Equity     HTML    112K 
21: R8          Consolidated Statements of Stockholders' Equity     HTML     36K 
                (Parenthetical)                                                  
22: R9          Consolidated Statements of Cash Flows               HTML    131K 
23: R10         Summary of Significant Accounting Policies          HTML     79K 
24: R11         Business Acquired                                   HTML     47K 
25: R12         Inventories, Net                                    HTML     45K 
26: R13         Property, Plant and Equipment, Net                  HTML     48K 
27: R14         Goodwill, Trademarks and Other Intangible Assets    HTML     84K 
28: R15         Accounts Payable and Accrued Liabilities            HTML     43K 
29: R16         Debt                                                HTML     63K 
30: R17         Other Liabilities                                   HTML     45K 
31: R18         Financial Instruments and Fair Value Measurements   HTML    122K 
32: R19         Other Contingencies, Guarantees and Commitments     HTML     49K 
33: R20         Leases                                              HTML    144K 
34: R21         Stockholders' Equity                                HTML     79K 
35: R22         Net Earnings Per Share (Eps)                        HTML     43K 
36: R23         Stock-Based Compensation Plans                      HTML     93K 
37: R24         Other (Income) Expense, Net                         HTML     55K 
38: R25         Income Taxes                                        HTML    118K 
39: R26         Employee Benefit Plans                              HTML    190K 
40: R27         Segment Reporting                                   HTML    148K 
41: R28         Related Party Transactions                          HTML     38K 
42: R29         Subsequent Event                                    HTML     36K 
43: R30         Summary of Significant Accounting Policies          HTML    138K 
                (Policies)                                                       
44: R31         Summary of Significant Accounting Policies          HTML     39K 
                (Tables)                                                         
45: R32         Business Acquired (Tables)                          HTML     44K 
46: R33         Inventories, Net (Tables)                           HTML     46K 
47: R34         Property, Plant and Equipment, Net (Tables)         HTML     46K 
48: R35         Goodwill, Trademarks and Other Intangible Assets    HTML     87K 
                (Tables)                                                         
49: R36         Accounts Payable and Accrued Liabilities (Tables)   HTML     43K 
50: R37         Debt (Tables)                                       HTML     59K 
51: R38         Other Liabilities (Tables)                          HTML     43K 
52: R39         Financial Instruments and Fair Value Measurements   HTML    114K 
                (Tables)                                                         
53: R40         Other Contingencies, Guarantees and Commitments     HTML     41K 
                (Tables)                                                         
54: R41         Leases (Tables)                                     HTML    105K 
55: R42         Stockholders' Equity (Tables)                       HTML     76K 
56: R43         Net Earnings Per Share (Eps) (Tables)               HTML     43K 
57: R44         Stock-Based Compensation Plans (Tables)             HTML     93K 
58: R45         Other (Income) Expense, Net (Tables)                HTML     55K 
59: R46         Income Taxes (Tables)                               HTML    124K 
60: R47         Employee Benefit Plans (Tables)                     HTML    196K 
61: R48         Segment Reporting (Tables)                          HTML    147K 
62: R49         Summary of Significant Accounting Policies          HTML     62K 
                (Additional Information) (Details)                               
63: R50         Summary of Significant Accounting Policies          HTML     53K 
                (Schedule of Estimated Useful Lives of Property,                 
                Plant and Equipment) (Details)                                   
64: R51         Business Acquired (Narrative) (Details)             HTML     72K 
65: R52         Business Acquired (Fair Value Of Assets Acquired    HTML     69K 
                and Liabilities Assumed) (Details)                               
66: R53         Inventories, Net (Inventory) (Details)              HTML     49K 
67: R54         Inventories, Net (Narrative) (Details)              HTML     35K 
68: R55         Property, Plant and Equipment, Net (Components of   HTML     55K 
                Property, Plant and Equipment, Net) (Details)                    
69: R56         Property, Plant and Equipment, Net (Narrative)      HTML     49K 
                (Details)                                                        
70: R57         Goodwill, Trademarks and Other Intangible Assets    HTML     59K 
                (Schedule of Goodwill) (Details)                                 
71: R58         Goodwill, Trademarks and Other Intangible Assets    HTML     56K 
                (Schedule of Intangible Assets, Excluding                        
                Goodwill) (Details)                                              
72: R59         Goodwill, Trademarks and Other Intangible Assets    HTML     59K 
                (Narrative) (Details)                                            
73: R60         Goodwill, Trademarks and Other Intangible Assets    HTML     54K 
                (Impairment Charges) (Details)                                   
74: R61         Accounts Payable and Accrued Liabilities (Details)  HTML     47K 
75: R62         Debt (Narrative) (Details)                          HTML    137K 
76: R63         Debt (Long-term Debt, Net of Unamortized Discounts  HTML     70K 
                or Premiums) (Details)                                           
77: R64         Debt (Borrowing Capacity Under Other Financing      HTML     40K 
                Arrangements) (Details)                                          
78: R65         Other Liabilities (Schedule of Other Liabilities)   HTML     46K 
                (Details)                                                        
79: R66         Other Liabilities (Narrative) (Details)             HTML     42K 
80: R67         Financial Instruments and Fair Value Measurements   HTML    112K 
                (Narrative) (Details)                                            
81: R68         Financial Instruments and Fair Value Measurements   HTML     49K 
                (Schedule of the Effects of Derivative Instruments               
                Designated as Hedging Instruments) (Details)                     
82: R69         Financial Instruments and Fair Value Measurements   HTML    119K 
                (Schedule of Financial Instruments Measured at                   
                Fair Value) (Details)                                            
83: R70         Other Contingencies, Guarantees and Commitments     HTML     51K 
                (Narrative) (Details)                                            
84: R71         Other Contingencies, Guarantees and Commitments     HTML     50K 
                (Unrecorded Unconditional Purchase Obligations                   
                Disclosure) (Details)                                            
85: R72         Leases (Narrative) (Details)                        HTML     51K 
86: R73         Leases (Supplemental Balance Sheet Information      HTML     59K 
                Schedule) (Details)                                              
87: R74         Leases (Components of Lease Cost Schedule)          HTML     49K 
                (Details)                                                        
88: R75         Leases (Supplemental Cash Flow Information and      HTML     47K 
                Non-Cash Activity Schedule) (Details)                            
89: R76         Leases (Weighted-Average Remaining Lease Term and   HTML     45K 
                Discount Rate Schedule) (Details)                                
90: R77         Leases (Maturities of Lease Liabilities by Fiscal   HTML     75K 
                Year Schedule) (Details)                                         
91: R78         Stockholders' Equity (Narrative) (Details)          HTML     49K 
92: R79         Stockholders' Equity (Common Stock Dividends)       HTML     36K 
                (Details)                                                        
93: R80         Stockholders' Equity (Schedule of Changes in        HTML     72K 
                Accumulated Other Comprehensive Net (Losses)                     
                (Details)                                                        
94: R81         Net Earnings Per Share (Eps) (Details)              HTML     44K 
95: R82         Stock-Based Compensation Plans (Narrative)          HTML    106K 
                (Details)                                                        
96: R83         Stock-Based Compensation Plans (Compensation Cost   HTML     45K 
                and Related Income Tax Benefit) (Details)                        
97: R84         Stock-Based Compensation Plans (Assumptions         HTML     69K 
                Utilized in the Valuation in Calculating the                     
                Compensation Expense for Stock Options Granted)                  
                (Details)                                                        
98: R85         Stock-Based Compensation Plans (Summary of Stock    HTML     75K 
                Option Activity) (Details)                                       
99: R86         Stock-Based Compensation Plans (Summary of          HTML     59K 
                Restricted Stock Award Activity) (Details)                       
100: R87         Stock-Based Compensation Plans (Summary of          HTML     62K  
                Performance Stock Award Activity) (Details)                      
101: R88         Other (Income) Expense, Net (Details)               HTML     60K  
102: R89         Income Taxes (Provision for Income Taxes by Tax     HTML     75K  
                Jurisdiction and Domestic and Foreign Earnings                   
                before Taxes) (Details)                                          
103: R90         Income Taxes (Effective Income Tax Rate             HTML     52K  
                Reconciliation) (Details)                                        
104: R91         Income Taxes (Narrative) (Details)                  HTML     63K  
105: R92         Income Taxes (Components of Net Deferred Tax        HTML     70K  
                Assets) (Details)                                                
106: R93         Income Taxes (Valuation Allowance) (Details)        HTML     41K  
107: R94         Income Taxes (Unrecognized Tax Benefits) (Details)  HTML     50K  
108: R95         Employee Benefit Plans (Narrative) (Details)        HTML     60K  
109: R96         Employee Benefit Plans (Summarized Information for  HTML    108K  
                Defined Benefit Retirement Income and Healthcare                 
                Plans) (Details)                                                 
110: R97         Employee Benefit Plans (Information for Retirement  HTML     54K  
                Income Plans with Accumulated Benefit Obligation                 
                in Excess of Plan Assets) (Details)                              
111: R98         Employee Benefit Plans (Components of the Net Cost  HTML     61K  
                of Retirement Income and Health Care Plans)                      
                (Details)                                                        
112: R99         Employee Benefit Plans (Items Not Yet Recognized    HTML     52K  
                as a Component of Postretirement Expense)                        
                (Details)                                                        
113: R100        Employee Benefit Plans (Net Actuarial Loss (Gain)   HTML     48K  
                and Prior Service Cost (Benefit) Activity Recorded               
                in Accumulated Other Comprehensive Loss (Income))                
                (Details)                                                        
114: R101        Employee Benefit Plans (Weighted-Average            HTML     60K  
                Assumptions Used to Estimate the Net Periodic                    
                Pension and Other Postretirement Benefit Costs)                  
                (Details)                                                        
115: R102        Employee Benefit Plans (Expected Benefit Payments)  HTML     53K  
                (Details)                                                        
116: R103        Employee Benefit Plans (Target Allocations and      HTML     50K  
                Weighted Average Asset Allocations) (Details)                    
117: R104        Employee Benefit Plans (Retirement Income Plan's    HTML     53K  
                Assets Carried at Fair Value) (Details)                          
118: R105        Segment Reporting (Narrative) (Details)             HTML     43K  
119: R106        Segment Reporting (Selected Financial Information   HTML    108K  
                Relating To Company's Segments) (Details)                        
120: R107        Segment Reporting (Concentration Percentages)       HTML     74K  
                (Details)                                                        
121: R108        Segment Reporting (Net Sales and Long-Lived Assets  HTML     47K  
                by Geographic Area) (Details)                                    
122: R109        Related Party Transactions (Details)                HTML     40K  
123: R110        Subsequent Event (Details)                          HTML     38K  
124: R9999       Uncategorized Items - _IXDS                         HTML     53K  
127: XML         IDEA XML File -- Filing Summary                      XML    250K  
125: XML         XBRL Instance -- clx-20220630_htm                    XML   4.01M  
126: EXCEL       IDEA Workbook of Financial Reports                  XLSX    244K  
10: EX-101.CAL  XBRL Calculations -- clx-20220630_cal                XML    343K 
11: EX-101.DEF  XBRL Definitions -- clx-20220630_def                 XML   1.13M 
12: EX-101.LAB  XBRL Labels -- clx-20220630_lab                      XML   2.78M 
13: EX-101.PRE  XBRL Presentations -- clx-20220630_pre               XML   1.77M 
 9: EX-101.SCH  XBRL Schema -- clx-20220630                          XSD    267K 
128: JSON        XBRL Instance as JSON Data -- MetaLinks              683±  1.07M  
129: ZIP         XBRL Zipped Folder -- 0000021076-22-000026-xbrl      Zip    772K  


‘EX-99.2’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 99.2
THE CLOROX COMPANY
RECONCILIATION OF ECONOMIC PROFIT (UNAUDITED) (1)
Dollars in millionsFY22FY21FY20
Earnings before income taxes$607 $900 $1,185 
Add back:
Certain U.S. GAAP charges (2)(3)
61 357 
Interest expense106 99 99 
Less:
Saudi JV acquisition gain (4)
— (82)— 
Earnings before income taxes,
certain U.S. GAAP items and interest expense
774 1,274 1,286 
Less:
Income taxes on earnings before
income taxes, certain U.S. GAAP items and interest expense (5)
174 264 267 
Adjusted after tax profit600 1,010 1,019 
Less: After tax profit attributable to noncontrolling interests— 
Adjusted after tax profit attributable to Clorox591 1,001 1,019 
Average capital employed (6)
3,428 3,655 3,478 
Less: Capital charge (7)
309 329 313 
Economic profit (1) (Adjusted after tax profit attributable to Clorox less capital charge)
$282 $672 $706 

(1)    Economic profit (EP) is defined by the Company as earnings before income taxes, excluding certain U.S. GAAP items (such as asset impairments, charges related to digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other non-recurring or unusual items) and interest expense; less income taxes (calculated based on the Company’s effective tax rate excluding the identified U.S. GAAP items), and less after tax profit attributable to noncontrolling interests, and less a capital charge (calculated as average capital employed multiplied by a cost of capital rate). EP is a key financial metric that the Company’s management uses to evaluate business performance and allocate resources, and is a component in determining employee incentive compensation. The Company’s management believes EP provides additional perspective to investors about financial returns generated by the business and represents profit generated over and above the cost of capital used by the business to generate that profit
(2)    Fiscal year 2022 includes $61 ($47 after tax) of incremental operating expenses primarily recorded within selling and administrative expenses related to the implementation related to the Company's digital capabilities and productivity enhancements investment, which are recorded within the Corporate segment. The expenses relate to the following:
Twelve Months Ended
June 30, 2022
External consulting fees (a)
$43 
IT project personnel costs (b)
11 
Other (c)
Total$61 
(a) Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.
(b) Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business.
(c) Comprised of various other expenses associated with the company’s new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses.
(3)    Fiscal year 2021 includes impairment charges of $329 (after tax $267) of which $228, $93, and $8 related to the goodwill of the Vitamins, Minerals and Supplements (VMS) business, certain indefinite-lived trademarks and other assets, respectively, and non-cash charges of $28 ($21 after tax) on investments and related arrangements made with a Professional Products business supplier.
(4)    On July 9, 2020, the Company increased its investment in each of the two entities comprising its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture). As a result of this transaction, a non-cash nonrecurring net gain was recognized of $82 ($76 after tax) in Other (income) expense, net in the quarter ended September 30, 2020, primarily due to the remeasurement of the carrying value of the company’s previously held equity investment to fair value.







(5)    The tax rate applied is the effective tax rate before the identified U.S. GAAP items was 22.5%, 20.7% and 20.8% in fiscal years 2022, 2021, and 2020, respectively. The difference between the fiscal year 2022 effective tax rate on earnings of 22.4% is due to the tax rate impact of the incremental operating expenses recorded related to the implementation of the Company’s digital capabilities and productivity enhancements investment of 0.1%. The difference between the fiscal year 2021 effective tax rate on earnings of 20.1% is due to the tax rate impact of the Professional Products supplier charge, VMS impairment, and Saudi JV acquisition gain of 0.1%, (0.4)%, and 0.9%, respectively.
(6)    Total capital employed represents total assets less non-interest bearing liabilities. Adjusted capital employed represents total capital employed adjusted to add back current year after tax U.S. GAAP items, as applicable, and deduct the current year after tax non-cash, non-recurring gain. Average capital employed is the average of adjusted capital employed for the current year and total capital employed for the prior year, based on year-end balances. See below for details of the average capital employed calculation.
(7)    Capital charge represents average capital employed multiplied by a cost of capital, which was 9% for all fiscal years presented. The calculation of capital charge includes the impact of rounding numbers.
Dollars in millionsFY22FY21FY20
Total assets$6,158 $6,334 $6,213 
Less:
       Accounts payable and accrued liabilities (8)
1,463 1,670 1,327 
Current operating lease liabilities78 81 64 
Income taxes payable— — 25 
Long-term operating lease liabilities314 301 278 
       Other liabilities (8)
778 819 755 
Deferred income taxes66 67 62 
Non-interest bearing liabilities2,699 2,938 2,511 
Total capital employed (6)
3,459 3,396 3,702 
After tax certain U.S. GAAP items(3)(4)
02122
Adjusted capital employed (6)
$3,459 $3,608 $3,704 
Average capital employed$3,428 $3,655 $3,478 

(8)    Accounts payable and accrued liabilities and Other liabilities are adjusted to exclude interest-bearing liabilities.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:8/10/22
For Period end:6/30/224
9/30/2010-Q,  4
7/9/20
 List all Filings 


30 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  Clorox Co./DE                     8-K:8,9     5/05/22   16:989K                                   Donnelley … Solutions/FA
 3/28/22  Clorox Co./DE                     8-K:1,2,9   3/25/22   11:881K                                   DG3/FA
11/17/21  Clorox Co./DE                     8-K:5,9    11/17/21   12:487K                                   DG3/FA
11/01/21  Clorox Co./DE                     10-Q        9/30/21   60:5.9M
10/06/21  Clorox Co./DE                     DEF 14A    11/17/21    1:4.3M                                   DG3/FA
 2/04/21  Clorox Co./DE                     10-Q       12/31/20   59:7.1M
11/02/20  Clorox Co./DE                     10-Q        9/30/20   63:6.3M
 5/08/20  Clorox Co./DE                     8-K:8,9     5/05/20   13:430K                                   Donnelley … Solutions/FA
10/31/19  Clorox Co./DE                     10-Q        9/30/19   63:6.7M
 8/14/19  Clorox Co./DE                     10-K        6/30/19  122:16M
 8/14/18  Clorox Co./DE                     10-K        6/30/18  128:15M
 5/09/18  Clorox Co./DE                     8-K:8,9     5/07/18    4:242K                                   Donnelley … Solutions/FA
 5/02/18  Clorox Co./DE                     10-Q        3/31/18   60:4.9M
 2/02/18  Clorox Co./DE                     10-Q       12/31/17   58:4.8M
 9/28/17  Clorox Co./DE                     8-K:8,9     9/26/17    4:241K                                   Donnelley … Solutions/FA
 9/30/16  Clorox Co./DE                     10-K/A      6/30/16    4:2.7M                                   DG3/FA
 9/15/16  Clorox Co./DE                     8-K:5,9     9/13/16    3:168K                                   DG3/FA
 8/16/16  Clorox Co./DE                     10-K        6/30/16  132:10M                                    DG3/FA
12/09/14  Clorox Co./DE                     8-K:8,9    12/04/14    4:218K                                   Donnelley … Solutions/FA
12/04/14  Clorox Co./DE                     S-3ASR     12/04/14   10:1M                                     Donnelley … Solutions/FA
11/02/12  Clorox Co./DE                     10-Q        9/30/12   50:2.4M                                   DG3/FA
11/03/11  Clorox Co./DE                     10-Q        9/30/11   50:2.6M                                   DG3/FA
 8/26/11  Clorox Co./DE                     10-K        6/30/11  116:16M                                    DG3/FA
 7/19/11  Clorox Co./DE                     8-K:1,3,5,8 7/18/11    4:321K                                   DG3/FA
 5/04/11  Clorox Co./DE                     10-Q        3/31/11   55:4.5M                                   DG3/FA
 5/04/10  Clorox Co./DE                     10-Q        3/31/10   33:2M                                     DG3/FA
11/03/09  Clorox Co./DE                     10-Q        9/30/09   16:1.1M                                   DG3/FA
 8/19/08  Clorox Co./DE                     10-K        6/30/08   11:1.5M                                   Donnelley … Solutions/FA
 5/02/08  Clorox Co./DE                     10-Q        3/31/08   12:1M                                     Donnelley … Solutions/FA
 8/27/04  Clorox Co./DE                     10-K        6/30/04   34:4.8M
Top
Filing Submission 0000021076-22-000026   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 3:37:52.2pm ET